Insulin glargine and lixisenatide Subcutaneous and Tenofovir Disoproxil Fumarate
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Tenofovir Disoproxil Fumarate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: tenofovir
Brand name: Vemlidy, Viread
Synonyms: Tenofovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Tenofovir Disoproxil Fumarate Oral Powder
- Insulin glargine and lixisenatide Subcutaneous-Tenofovir Disoproxil Fumarate Tablets
- Insulin glargine and lixisenatide Subcutaneous-Tenoretic
- Insulin glargine and lixisenatide Subcutaneous-Tenoretic 100
- Insulin glargine and lixisenatide Subcutaneous-Tenoretic 50
- Insulin glargine and lixisenatide Subcutaneous-Tenormin
- Tenofovir Disoproxil Fumarate-Insulin glargine, recombinant Subcutaneous
- Tenofovir Disoproxil Fumarate-Insulin glulisine
- Tenofovir Disoproxil Fumarate-Insulin Glulisine (Cartridges and Pens)
- Tenofovir Disoproxil Fumarate-Insulin Glulisine (Vials)
- Tenofovir Disoproxil Fumarate-Insulin glulisine Subcutaneous
- Tenofovir Disoproxil Fumarate-Insulin human inhaled Inhalation